Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 5155-5159

  Tadbir, Azadeh Andisheh ^a   Pardis, Soheil ^a   Ashkavandi, Zohreh Jafari ^a   Najvani, Ali Dehghani ^a   Ashraf, Mohammad Javad ^b   Taheri, Ali ^c   Zadeh, Maryam Asad ^c   Sardari, Yasaman ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiogenesis; CD105; Ki67; Proliferation; Salivary gland tumor

Indexed keywords

EID: 84874015493     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.5155     Document Type: Article

References (31)

1. Ali AM, Ueno T, Tanaka S, et al (2011). Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients. Eur J Cancer, 47, 2265-72.
2. Alves F, Pires F, de Almedia O, Lopes M, Kowalski L(2004). PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg, 33, 593-7.
3. Barsky SH, Karlin NJ (2005). Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland BiolNeoplasia, 10, 249-260.
4. Brewer CA, Setterdahl JJ, Li MJ, et al (2000). Endoglin expression as a measure of microvessel density in cervical cancer. Obstet gynecol, 96, 224-8.
5. Bullwinkel J, Baron-Lühr B, Lüdemann A, Wohlenberg C, Gerdes J, Scholzen T(2006). Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol, 206, 624-35.
6. Cardoso S, Souza K, Faria P, Eisenberg A, Dias F(2009). Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior. BMC Cancer, 9, 391-400.
7. Costa A, Demasi A, Bonritto V, et al(2008). Angiogenesis in salivary carcinomas with and without myoepithelial differentiation. Virchows Arch, 453, 359-67.
8. Dallas NA, Samuel S, Xia L, et al (2008). Endoglin(CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res, 14, 1931-7.
9. Duff SE, Li C, Garland JM, Kumar S (2003). CD105 is important for angiogenesis: evidence and potential applications. The FASEB J, 17, 984-91.
10. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M (2003). Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene, 22, 6557-63.
11. Fonseca I, Felix A, Soares J (1997). Cell proliferationin salivary gland adenocarcinomas with myoepithelial participation. Astudy of 78 cases. Virchows Arch, 430, 227-32.
12. Goumans MJ, Lebrin F, Valdimarsdottir G. Controlling the angiogenic switch (2003). Controlling the angiogenic switch:a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med,13,301-7.
13. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
14. Hillen F, Griffioen AW (2007). Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev, 26, 489-502.
15. Hollstein M, Sidransky D, Volgelstein B, Harris C (1991).p53 mutations in human cancers. Science, 253, 49-53.
16. Kubota Y(2012). Tumor Angiogenesis and Anti-angiogenic Therapy. Keio J Med, 61, 47-56.
17. Lazzaro B, Cleveland D (2000). p53 and Ki-67 antigen expression in small oral biopsy specimens of salivary gland tumours. OralSurg Oral Med Oral PatholOralRadiolEndod,89, 613-617.
18. Levi B, Wan DC, Glotzbach JP, et al (2011). CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of transforming growth factor β1 (TGF-β1) signaling. J Biol Chem, 286, 39497-509.
19. Liu P, Sun YL, Du J, Hou XS, Meng H (2012). CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer. Int J Gynecol Cancer, 22, 586-92.
20. MacCallum DE, Hall PA (2000). The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol, 190,537-44.
21. Meng CD, Zhu DD, Jiang XD, et al (2012). Overexpression of interleukin-l7 in tumor-associated macrophages is correlated with the differentiation and angiogenesis of laryngeal squamous cell carcinoma. Chin Med J (Engl), 125, 1603-7.
22. Minhajat R, Mori D, Yamasaki F, et al (2006). Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int, 56, 717-23.
23. Nassiri F, Cusimano MD, Scheithauer BW, et al (2011). Endoglin(CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res, 31, 2283-90.
24. Nguyen M, Lee MC, Wang JL, et al (2000). The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene, 19, 3449-59.
25. Nordgard S, Franzén G, Boysen M, Halvorsen TB (1997). Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB 1 in paraffin sections.Laryngoscope, 107,531-6.
26. Rahmanzadeh R, Hüttmann G, Gerdes J, Scholzen T (2007). Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis". Cell Prolif, 40, 422-3.
27. Romani AA, Borghetti AF, Del Rio P, Sianesi M, SolianiP (2006).The risk of developing metastatic disease in colorectal cancer is related to CD105-positive count. J SurgOncol, 93, 446-55
28. Scalzo DA, Kallakury BV, Gaddipati RV, et al (1998) Cell proliferation rate by MIB-1 immunohistochemistry predicts postradiation recurrence in prostatic adenocarcinomas. Am J ClinPathol, 109, 163-8.
29. Scholzen T, Gerdes J (2000). The Ki-67 protein: from the known and the unknown". J Cell Physiol, 182, 311-22.
30. Sharma S, Sharma MC, Sarkar C (2005). Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology, 46, 481-9.
31. Zijlmans HJ, Fleuren GJ, Hazelbag S, Sier CF, Dreef EJ, Kenter GG, Gorter A (2009). Expression of endoglin (CD105) in cervical cancer. Br J Cancer, 100, 1617-26.